Companion Animal Drugs Market - Top Companies and Manufacturers

Companies Dominating the Companion Animal Drugs Landscape

The current leading companies in the companion animal drugs market are focusing on integrating technological advancements to gain global recognition. They are developing connective platforms to bring innovation in this sector. In addition, advancements in technologies also ignite R&D, creating a scope for future development in this sector. For instance, in March 2024, Boehringer Ingelheim acquired Saiba Animal Health to incorporate the innovative technology platform of Saiba for accelerating its R&D on therapeutics. This acquisition will allow the global leader to access Saiba’s therapeutic vaccine approach to create an immune response, defending allergy, inflammation, and pain in pets. Such key players include:

Agrolabo S.p.A.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Boehringer Ingelheim International GmbH
Ceva Santé Animale
Chanelle Pharma
Dechra Pharmaceuticals PLC
Elanco Animal Health Incorporated
Endovac Animal Health
HIPRA
Indian Immunologicals Ltd.
Merck & Co., Inc.
Norbrook
Symrise
Vetoquinol
Virbac
Zoetis Inc.
Akston

Browse Key Market Insights with Data Illustration:

Companion Animal Drugs Market Size & Share, Growth Forecasts 2037

In the News

In August 2024, Akston partnered with Energesis to accelerate their R&D in obesity drugs for companion animals. The collaboration will allow Akston to utilize the biologic BAT recruitment therapy of Energesis to enhance the natural ability of pets to burn more calories by increasing energy use.
In July 2024, Dechra acquired Invetx to expand its portfolio of innovative companion animal health products. Invetx’s expertise in protein-based therapeutics will add a specialty product line to treat chronic conditions of dogs and cats.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of the companion animal drugs market was over USD 21.3 billion.

The market size for the companion animal drugs market is projected to reach USD 51.8 billion by the end of 2037 expanding at a CAGR of 7.7% during the forecast period i.e., between 2025-2037.

The major players in the market are Agrolabo S.p.A., Boehringer Ingelheim International GmbH, Ceva Santé Animale, Chanelle Pharma, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Endovac Animal Health, HIPRA, Indian Immunologicals Ltd., Merck & Co., Inc., Norbrook, Symrise, Vetoquinol, Virbac, Zoetis Inc., and others.

In terms of products, the drugs segment is anticipated to garner the largest market share of 55.1% by 2037 and display lucrative growth opportunities during 2025-2037.

The market in North America is projected to hold the largest market share of 41.1% by the end of 2037 and provide more business opportunities in the future.

Companion Animal Drugs Market - Top Companies and Manufacturers

Companies Dominating the Companion Animal Drugs Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the companion animal drugs market?

What is the outlook for the companion animal drugs market?

Who are the major players dominating the companion animal drugs market?

Which product segment will capture the significant market share for the companion animal drugs market by 2037?

Which region will provide more business opportunities for the growth of the companion animal drugs market in the future?